Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma-Reference-Cited by-同舟云学术

Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma

Published:2015-07-31 Issue:1 Volume:90 Page:61-72
ISSN:1552-4949
Container-title:Cytometry Part B: Clinical Cytometry
language:en
Short-container-title:Cytometry

Author:

Flores-Montero Juan¹,de Tute Ruth²,Paiva Bruno³,Perez José Juan⁴,Böttcher Sebastian⁵,Wind Henk⁶,Sanoja Luzalba¹,Puig Noemí⁴,Lecrevisse Quentin¹,Vidriales María Belén⁴,van Dongen Jacques J. M.⁶,Orfao Alberto¹

Affiliation:

1. Centro de Investigación del Cáncer (Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL), Instituto Biosanitario de Salamanca (IBSAL), Servicio de Citometría y Departamento de Medicina-NUCLEUS, Universidad de Salamanca (Salamanca); Spain

2. Haematological Malignancy Diagnostic Service, St James Institute of Oncology, Leeds Teaching Hospitals; Leeds United Kingdom

3. Clínica Universidad de Navarra, Centro de Investigaciones Médicas Aplicadas (CIMA); Pamplona Spain

4. Department of Hematology; Hospital Universitario de Salamanca, Instituto Biosanitario de Salamanca (IBSAL), Centro de Investigación del Cáncer (Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL); Salamanca Spain

5. Second Department of Medicine; University Hospital of Schleswig Holstein, Campus Kiel (UNIKIEL); Kiel Germany

6. Department of Immunology; Erasmus MC, University Medical Center Rotterdam (Erasmus MC); Rotterdam The Netherlands

Funder

Red Temática de Investigación Cooperativa en Cáncer (RTICC) of the Instituto de Salud Carlos III (Ministry of Economy and Competitivity, Madrid, Spain) - FEDER

EuroFlow Consortium; the International Myeloma Foundation-Black Swan Research Initiative

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Reference75 articles.

1. Flow cytometric disease monitoring in multiple myeloma: The relationship between normal and neoplastic plasma cells predicts outcome after transplantation;Rawstron;Blood,2002

2. Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: A tool for comparing the efficacy of different treatment strategies and predicting outcome;San Miguel;Blood,2002

3. New criteria for response assessment: Role of minimal residual disease in multiple myeloma;Paiva;Blood,2015

4. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes;Dongen;Leukemia,2012

5. Overview of clinical flow cytometry data analysis: Recent advances and future challenges;Pedreira;Trends Biotechnol,2013

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune monitoring of patients treated with anti-CD20 therapeutic monoclonals for autoimmune disorders;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

2. Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma;Therapeutic Advances in Medical Oncology;2024-01

3. Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM);Annals of Hematology;2023-12-05

4. Flow Cytometry in Diagnosis, Prognostication, and Monitoring of Multiple Myeloma and Related Disorders;Clinics in Laboratory Medicine;2023-09

5. MULTIPARAMETRIC FLOW CYTOMETRY REFINES RISK STRATIFICATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS;Mediterranean Journal of Hematology and Infectious Diseases;2023-08-29